ロード中...
Role of MetMAb (OA-5D5) in c-MET active lung malignancies
INTRODUCTION: MetMAb (OA-5D5) is a one-armed monoclonal antibody developed to bind to and inhibit c-MET receptor tyrosine kinase. Though early in clinical testing, this agent holds great promise in diseases thought to be driven by c-MET activation, as evidenced by the phase II results in non-small c...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3258451/ https://ncbi.nlm.nih.gov/pubmed/22047509 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2011.626762 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|